Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $2.48 billion. The companyÂ’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 96.37 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.
The Asia Tigers Fund, Inc. (GRR) formed multiple top with $12.83 target or 4.00% above today’s $12.34 share price. The Asia Tigers Fund, Inc. (GRR) has $ valuation. It closed at $12.3404 lastly. It is down 37.03% since December 8, 2016 and is uptrending. It has outperformed by 20.33% the S&P500.
Investors sentiment decreased to 0.4 in Q2 2017. Its down 1.35, from 1.75 in 2017Q1. It is negative, as 2 investors sold The Asia Tigers Fund, Inc. shares while 3 reduced holdings. 0 funds opened positions while 2 raised stakes. 1.53 million shares or 0.78% more from 1.52 million shares in 2017Q1 were reported. Florida-based Thomas J Herzfeld Advsrs has invested 0.01% in The Asia Tigers Fund, Inc. (NYSE:GRR). Morgan Stanley invested in 785 shares. Moreover, Royal Natl Bank Of Canada has 0% invested in The Asia Tigers Fund, Inc. (NYSE:GRR) for 5,514 shares. Fincl Bank Of America De reported 20,000 shares stake. Css Limited Liability Il owns 14,872 shares or 0.01% of their US portfolio. Wells Fargo And Com Mn reported 19,499 shares. Bulldog Ltd invested in 0.49% or 161,657 shares. The Virginia-based 1607 Capital Ptnrs Limited Liability Corporation has invested 0.13% in The Asia Tigers Fund, Inc. (NYSE:GRR). City Of London Management Com Ltd holds 1.02% or 1.12 million shares in its portfolio. Blue Bell Private Wealth Management Limited Liability Company has 0.01% invested in The Asia Tigers Fund, Inc. (NYSE:GRR).
The stock increased 2.01% or $2.34 during the last trading session, reaching $118.63. About 57,288 shares traded. Inogen, Inc. (INGN) has risen 88.09% since December 8, 2016 and is uptrending. It has outperformed by 71.39% the S&P500.
Analysts await Inogen, Inc. (NASDAQ:INGN) to report earnings on February, 27. They expect $0.21 EPS, down 16.00% or $0.04 from last year’s $0.25 per share. INGN’s profit will be $4.38 million for 141.23 P/E if the $0.21 EPS becomes a reality. After $0.33 actual EPS reported by Inogen, Inc. for the previous quarter, Wall Street now forecasts -36.36% negative EPS growth.
Brown Capital Management Llc holds 2.61% of its portfolio in Inogen, Inc. for 2.23 million shares. Tirschwell & Loewy Inc owns 166,140 shares or 2.49% of their US portfolio. Moreover, Oberweis Asset Management Inc has 1.83% invested in the company for 69,950 shares. The Wisconsin-based Timpani Capital Management Llc has invested 1.76% in the stock. Cortina Asset Management Llc, a Wisconsin-based fund reported 369,576 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.